CYP19A1 and breast carcinoma: In a first step to test this, human bone tissue fragments were cultured in the presence vs. absence of aromatase inhibitors, and the supernatants were used to culture ER+ and ER- breast cancer cell lines, as shown schematically in Fig. 4a.